Plasma Aβ(42):Aβ(40) ratio as a biomarker for cognitive impairment in haemodialysis patients: a multicentre study

BACKGROUND: Mild cognitive impairment (MCI) and dementia are more prevalent in patients undergoing haemodialysis (HD). Although the cerebrospinal fluid amyloid beta (Aβ) and tau (τ) have proven to be valid biomarkers for the diagnosis of Alzheimer's disease (AD) in the general population, the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xujiao, Wang, Mengjing, Niu, Jianying, Ma, Jun, Qian, Jing, Ni, Li, Cheng, Ping, You, Huaizhou, Chen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616443/
https://www.ncbi.nlm.nih.gov/pubmed/37915896
http://dx.doi.org/10.1093/ckj/sfad173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616443/
https://www.ncbi.nlm.nih.gov/pubmed/37915896
http://dx.doi.org/10.1093/ckj/sfad173

Ejemplares similares